Company Filing History:
Years Active: 2013
Title: Gant Gallagher: Innovator in Medical Diagnostics
Introduction
Gant Gallagher is a notable inventor based in Milltown, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in understanding inflammatory bowel diseases. His work has implications for predicting and diagnosing conditions such as Crohn's disease.
Latest Patents
Gant Gallagher holds a patent for "Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a Δ9 isoform in predicting inflammatory bowel diseases." This patent discloses the cloning and identification of human IL-23R splice variants caused by alternative splicing of the IL-23R mRNA. A total of twenty-five different IL-23R transcripts were identified, including a novel exon deletion isoform denoted as Δ9. The application also describes a quantitative assay to measure different IL-23R isoforms. Notably, the Δ9 isoform is predominantly present in colon and cervical tissues, and a decrease in Δ9 is observed in inflamed colon tissues in Crohn's patients. This discovery provides a method for predicting Crohn's disease by measuring the Δ9 isoform of IL-23R.
Career Highlights
Gant Gallagher is associated with Medical Diagnostic Laboratories, LLC, where he applies his expertise in medical diagnostics. His innovative work has positioned him as a key figure in the research and development of diagnostic tools for inflammatory bowel diseases.
Collaborations
Gant has collaborated with notable colleagues such as Raymond Yu and Shih-hsin Kan, contributing to advancements in medical diagnostics and research.
Conclusion
Gant Gallagher's contributions to the field of medical diagnostics, particularly through his patent on IL-23R splice variants, highlight his role as an innovator in predicting inflammatory bowel diseases. His work continues to impact the medical community and improve diagnostic methodologies.